Jonathan A. Robbins

Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicineBiochemistry, Genetics and Molecular BiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial”.

Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial

Journal of Clinical Sleep Medicine(2024)10.5664/jcsm.11272

N/A

0.346DataRank · unranked

6 citations

Scott A. Sands, Lata Maganti, Tami Crumley, Sabrina Fox‐Bosetti, Azher Hussain +9 more

MK-7602: a potent multi-stage dual-targeting antimalarial

EBioMedicine(2025)10.1016/j.ebiom.2025.106061

N/A

0DataRank · unranked

6 citations

Josephine Palandri, Manuel de Lera Ruiz, Wendy Bailey, Christopher W. Boyce, Andrew Danziger +34 more